Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:assetsUnderManagement |
€250 million
|
| gptkbp:director |
Bernhard Mohr
|
| gptkbp:focusesOn |
digitalization
sustainability advanced materials specialty chemicals |
| gptkbp:foundedIn |
2012
|
| gptkbp:headquartersLocation |
gptkb:Essen,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Evonik Venture Capital
|
| gptkbp:investedIn |
early stage
growth stage |
| gptkbp:operatesIn |
gptkb:Asia
gptkb:Europe gptkb:North_America |
| gptkbp:parentCompany |
gptkb:Evonik_Industries
|
| gptkbp:portfolioCompany |
Bactolife
Chembid FRX Polymers MedLumics Numaferm SmartKem Synoste Vestaron |
| gptkbp:website |
https://venturing.evonik.com
|
| gptkbp:bfsParent |
gptkb:Bugworks
|
| gptkbp:bfsLayer |
7
|